Biogen (BIIB) Receivables - Net (2009 - 2026)
Biogen (BIIB) posted quarterly Receivables - Net of $1.9 billion for Q2 2026, up 16.09% year-over-year from $1.6 billion in Q2 2025, and up 37.72% quarter-over-quarter from $1.4 billion in Q1 2026.
Biogen (BIIB) Receivables - Net (2009 - 2026) Analysis & Trends
Biogen's Receivables - Net history runs 18 years deep, the most recent figure standing at $1.9 billion for Q2 2026.
- In Q2 2026, Receivables - Net rose 16.09% year-over-year to $1.9 billion; the TTM figure through Jun 2026 stood at $1.9 billion (up 16.09% YoY), while the FY2025 annual figure was $1.3 billion, down 4.44% from the prior year.
- Receivables - Net for Q2 2026 stood at $1.9 billion, up from $1.4 billion in the prior quarter.
- The five-year high for Receivables - Net was $1.9 billion in Q2 2026, with the low at $4.4 million in Q4 2025.
- The 5-year median for Receivables - Net is $1.6 billion (2024), against an average of $1.5 billion.
- The sharpest annual moves came in 2025 and 2026: Receivables - Net slumped 99.69% in 2025, then increased 16.09% in 2026.
- Biogen's Receivables - Net stood at $1.7 billion in 2022, then slipped by 2.4% to $1.7 billion in 2023, then fell by 15.58% to $1.4 billion in 2024, then plunged by 99.69% to $4.4 million in 2025, then jumped by 42754.55% to $1.9 billion in 2026.
- Business Quant data shows BIIB's Receivables - Net at $1.9 billion in Q2 2026, $1.4 billion in Q1 2026, and $4.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Biogen | 32.04 Bn | 30.76 Bn | 1.96 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.89 Bn |
| Jun 30, 2026 | 1.89 Bn |
| Mar 31, 2026 | 1.37 Bn |
| Mar 31, 2026 | 1.37 Bn |
| Dec 31, 2025 | 4.40 Mn |
| Dec 31, 2025 | 4.40 Mn |
| Sep 30, 2025 | 1.37 Bn |
| Sep 30, 2025 | 1.37 Bn |
| Jun 30, 2025 | 1.62 Bn |
| Jun 30, 2025 | 1.62 Bn |
| Mar 31, 2025 | 1.60 Bn |
| Mar 31, 2025 | 1.60 Bn |
| Dec 31, 2024 | 1.40 Bn |
| Dec 31, 2024 | 1.40 Bn |
| Sep 30, 2024 | 1.54 Bn |
| Sep 30, 2024 | 1.54 Bn |
| Jun 30, 2024 | 1.63 Bn |
| Jun 30, 2024 | 1.63 Bn |
| Mar 31, 2024 | 1.60 Bn |
| Mar 31, 2024 | 1.60 Bn |